Genotype patterns that contribute to increased risk for or protection from developing heroin addiction
- PMID: 18195715
- PMCID: PMC3810149
- DOI: 10.1038/sj.mp.4002147
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction
Abstract
A genome-wide association study was conducted using microarray technology to identify genes that may be associated with the vulnerability to develop heroin addiction, using DNA from 104 individual former severe heroin addicts (meeting Federal criteria for methadone maintenance) and 101 individual control subjects, all Caucasian. Using separate analyses for autosomal and X chromosomal variants, we found that the strongest associations of allele frequency with heroin addiction were with the autosomal variants rs965972, located in the Unigene cluster Hs.147755 (experiment-wise q=0.053), and rs1986513 (q=0.187). The three variants exhibiting the strongest association with heroin addiction by genotype frequency were rs1714984, located in an intron of the gene for the transcription factor myocardin (P=0.000022), rs965972 (P=0.000080) and rs1867898 (P=0.000284). One genotype pattern (AG-TT-GG) was found to be significantly associated with developing heroin addiction (odds ratio (OR)=6.25) and explained 27% of the population attributable risk for heroin addiction in this cohort. Another genotype pattern (GG-CT-GG) of these variants was found to be significantly associated with protection from developing heroin addiction (OR=0.13), and lacking this genotype pattern explained 83% of the population attributable risk for developing heroin addiction. Evidence was found for involvement of five genes in heroin addiction, the genes coding for the mu opioid receptor, the metabotropic receptors mGluR6 and mGluR8, nuclear receptor NR4A2 and cryptochrome 1 (photolyase-like). This approach has identified several new genes potentially associated with heroin addiction and has confirmed the role of OPRM1 in this disease.
Figures
Similar articles
-
Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.Mol Diagn Ther. 2010 Jun 1;14(3):171-8. doi: 10.1007/BF03256370. Mol Diagn Ther. 2010. PMID: 20560679
-
A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.J Neurosci. 2014 Aug 13;34(33):11048-66. doi: 10.1523/JNEUROSCI.3986-13.2014. J Neurosci. 2014. PMID: 25122903 Free PMC article.
-
Genetic susceptibility to heroin addiction: a candidate gene association study.Genes Brain Behav. 2008 Oct;7(7):720-9. doi: 10.1111/j.1601-183X.2008.00410.x. Epub 2008 Jun 2. Genes Brain Behav. 2008. PMID: 18518925 Free PMC article.
-
OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.Pharmacogenomics. 2013 May;14(7):813-24. doi: 10.2217/pgs.13.57. Pharmacogenomics. 2013. PMID: 23651028 Review.
-
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.Ann N Y Acad Sci. 2010 Feb;1187:184-207. doi: 10.1111/j.1749-6632.2009.05275.x. Ann N Y Acad Sci. 2010. PMID: 20201854 Free PMC article. Review.
Cited by
-
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20. Neurosci Lett. 2013. PMID: 23454283 Free PMC article.
-
The genetics of the opioid system and specific drug addictions.Hum Genet. 2012 Jun;131(6):823-42. doi: 10.1007/s00439-012-1172-4. Epub 2012 May 1. Hum Genet. 2012. PMID: 22547174 Free PMC article. Review.
-
Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction.Psychiatr Genet. 2010 Oct;20(5):207-14. doi: 10.1097/YPG.0b013e32833a2106. Psychiatr Genet. 2010. PMID: 20520587 Free PMC article.
-
A review of opioid addiction genetics.Curr Opin Psychol. 2019 Jun;27:31-35. doi: 10.1016/j.copsyc.2018.07.014. Epub 2018 Aug 9. Curr Opin Psychol. 2019. PMID: 30118972 Free PMC article. Review.
-
Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond.Sci Rep. 2022 Oct 7;12(1):16873. doi: 10.1038/s41598-022-21003-y. Sci Rep. 2022. PMID: 36207451 Free PMC article.
References
-
- Kreek MJ. Gene diversity in the endorphin system: SNPs, chips, and possible implications. In: Yudell M, DaSalle R, editors. The Genomic Revolution: Unveiling the Unity of Life. Joseph Henry Press; Washington, DC: 2002. pp. 97–108.
-
- Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/ dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry. 2003;160:687–695. - PubMed
-
- Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 1998;55:967–972. - PubMed
-
- Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3372 twin pairs. Am J Med Genet. 1996;67:473–477. - PubMed
-
- LaForge KS, Yuferov V, Kreek MJ. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol. 2000;410:249–268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials